GTX INC Development Agreements
27 Contracts & Agreements
- the anticipated progress of our research, development and clinical programs, including whether any future clinical trials we conduct will achieve similar results to clinical... (Filed With SEC on March 8, 2011)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our research, development and clinical programs, including whether current and future clinical trials will achieve similar results to clinical trials... (Filed With SEC on March 15, 2010)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
- the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical... (Filed With SEC on March 3, 2009)
